Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 1 3Phase 2 2Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 678INDUSTRY 203NIH 80NETWORK 64OTHER_GOV 18UNKNOWN 2FED 2INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Prostatic Neoplasms 17Rare Diseases 3Neoplasms 3Neoplasm Metastasis 3Leukemia 3Recurrence 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Genetic Diseases, Inborn 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Squamous Cell 2Adenocarcinoma Of Esophagus 2Turcot syndrome 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Respiratory Aspiration 1Radiation Pneumonitis 1Prostate Cancer Diagnosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatosis 2 1Neurofibromatoses 1

Interventions

Enalapril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × FED × Lung Neoplasms × Clear all
NCT01754909 2019-10-08

Mitigation of Radiation Pneumonitis and Fibrosis

VA Office of Research and Development

Phase 2 Completed
50 enrolled 10 charts
Thoracic

Lung Neoplasms, Radiation Pneumonitis

NCT00780234 2019-04-11

Pioglitazone for Lung Cancer Chemoprevention

VA Office of Research and Development

Phase 2 Completed
92 enrolled 9 charts
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡